Its role Investor / Financier
The March Group is a thematic early-stage venture capital firm founded in 2018 and headquartered in Davis, California, in the United States.
The firm focuses on investing in companies that leverage exponential technologies to accelerate global industry paradigm shifts, with particular emphasis on precision nutrition, intelligent health, and the food and medicine sectors.
It maintains strong ties to the University of California system, sourcing opportunities from its extensive research ecosystem, which includes billions in annual funding and numerous startups.
The March Group has participated in funding rounds for biotechnology and food technology companies, including a 2024 investment in Danish firm EvodiaBio as part of its Series A round aimed at commercializing sustainable aroma production technology.
Led by experienced professionals including Harold Schmitz, Ph.D., former Chief Science Officer at Mars Inc., and venture capitalists with backgrounds at firms like Horizons Ventures, the firm operates as a private entity actively pursuing new investments while following principles for responsible investment.
Its activities position it within the broader venture capital industry supporting innovative startups in sustainable food systems and health technologies.
Also known as The March Fund.
chemXplore tracks 1 project involving The March Group.
The investment will fund commercialization and expansion of a sustainable aroma technology for improving non-alcoholic beer taste, reducing resource use, and lowering CO2 emissions.
active all projects